Effects of psychotropic polypharmacy intervention
Y. W. Francis Lam
Abstract
Y. W. Francis Lam
Abstract
Psychotropic polypharmacy, the concurrent use of two or more psychotropic drugs in the same patient, is a common practice in treating patients with psychiatric disorders. Such practices risk an increase in the incidence of drug interaction and adverse effects, as well as a decrease in medication adherence. A meta‐analysis of 26 studies that employed focused medication review with a goal of appropriate de‐prescribing reported significant reductions in the number of psychotropic drugs after the reviews, but there was little evidence of decreased incidence of adverse drug reactions or lower drug costs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Psychotropic polypharmacy, the concurrent use of two or more psychotropic drugs in the same patient, is a common practice in treating patients with psychiatric disorders. Such practices risk an increase in the incidence of drug interaction and adverse effects, as well as a decrease in medication adherence. A meta‐analysis of 26 studies that employed focused medication review with a goal of appropriate de‐prescribing reported significant reductions in the number of psychotropic drugs after the reviews, but there was little evidence of decreased incidence of adverse drug reactions or lower drug costs.
Key concepts: Polypharmacy, Medicine, Psychotropic drug, Drug, Adverse effect, Incidence (geometry), Intervention (counseling), Drug reaction